Advances Toward a Norovirus Antiviral: From Classical Inhibitors to Lethal Mutagenesis

Journal of Infectious Diseases

Volumn 213, Issue , 2016, Pages S27-S31

  Thorne, Lucy ^a   Arias, Armando ^a   Goodfellow, Ian ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

antivirals; favipiravir; human norovirus; interferon; lethal mutagenesis; polymerase; protease

Indexed keywords

ANTIVIRUS AGENT; GAMMA INTERFERON; INTERFERON; INTERFERON LAMBDA; PROTEIN NS6; RNA DIRECTED RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; ANTIPARASITIC AGENT; NITAZOXANIDE; THIAZOLE DERIVATIVE; VIRUS VACCINE;

ARTICLE; HOST CELL; HUMAN; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN TARGETING; VIRUS MUTATION; VIRUS REPLICATION; CALICIVIRIDAE INFECTIONS; DRUG EFFECTS; GASTROENTERITIS; GENETICS; VIROLOGY;

ANTIPARASITIC AGENTS; ANTIVIRAL AGENTS; CALICIVIRIDAE INFECTIONS; GASTROENTERITIS; HUMANS; MUTAGENESIS; NOROVIRUS; THIAZOLES; VIRAL VACCINES; VIRUS REPLICATION;

EID: 84961827283     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv280     Document Type: Article

References (19)

1. Payne DC, Vinje J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013; 368:1121-30.
2. Harris JP, Adams NL, Lopman BA, Allen DJ, Adak GK. The development of webbased surveillance provides new insights into the burden of norovirus outbreaks in hospitals in England. Epidemiol Infect 2014; 142:1590-8.
3. Ronchetti AM, Henry B, Ambert-Balay K, et al. Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia. BMC Infect Dis 2014; 14:239.
4. Woodward JM, Gkrania-Klotsas E, Cordero-Ng AY, et al. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol 2015; 110:320-7.
5. Patel MM, Widdowson M-A, Glass RI, Akazawa K, Vinjé J, Parashar UD. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008; 14:1224-31.
6. Arias A, Emmott E, Vashist S, Goodfellow I. Progress towards the prevention and treatment of norovirus infections. Future Microbiol 2013; 8:1475-87.
7. Jones MK,Watanabe M, Zhu S, et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science 2014; 346:755-9.
8. Taube S, Kolawole AO, Hohne M, et al. A mouse model for human norovirus. MBio 2013; 4:00450-13.
9. Katayama K, Murakami K, Sharp TM, et al. Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA. Proc Natl Acad Sci U S A 2014; 111:5.
10. Kaufman SS, Green KY, Korba BE. Treatment of norovirus infections: moving antivirals from the bench to the bedside. Antiviral Res 2014; 105:80-91.
11. Nice TJ, Baldridge MT, McCune BT, et al. Interferon lambda cures persistent murine norovirus infection in the absence of adaptive immunity. Science 2014; 27:1258100.
12. Rocha-Pereira J, Nascimento MS, Ma Q, Hilgenfeld R, Neyts J, Jochmans D. The enterovirus protease inhibitor rupintrivir exerts cross-genotypic anti-norovirus activity and clears cells from the norovirus replicon. Antimicrob Agents Chemother 2014; 58:4675-81.
13. Ferrer-Orta C, Arias A, Escarmís C, Verdaguer N. A comparison of viral RNA-dependent RNA polymerases. Curr Opin Struct Biol 2006; 16:27-34.
14. Rocha-Pereira J, Jochmans D, Neyts J. Prophylactic treatment with the nucleoside analogue 2?-C-methylcytidine completely prevents transmission of norovirus. J Antimicrob Chemother 2015; 70:190-7.
15. Eltahla AA, Lim KL, Eden JS, Kelly AG, Mackenzie JM, White PA. Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design. Antimicrob Agents Chemother 2014; 58:3115-23.
16. Gonzalez-Hernandez MJ, Pal A, Gyan KE, et al. Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses. PLoS One 2014; 9:e94491.
17. Arias A, Thorne L, Goodfellow I. Favipiravir elicits antiviral mutagenesis during virus replication in vivo. Elife 2014; 3:e03679.
18. Domingo E, Sheldon J, Perales C. Viral quasispecies evolution. Microbiol Mol Biol Rev 2012; 76:159-216.
19. Woodward JM, Gkrania-Klotsas E, Cordero-Ng AY, et al. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol 2015; 110:320-7.